Overnight, Argentina discovered cannabis exports and turned all its power on developing an industry that is still being repressed. The man chosen by President Alberto Fernandez to promote cannabis exports in Argentina is his Minister of Productive Development, Matias Kulfas. He was the one who brought together other national cabinet departments interested in the herb and put together a plan to promote the development of the industry.
This initiative, presented in society just two weeks ago, has already entered Congress where it will be given an express treatment to achieve what everyone wants, the exportation of cannabis. In an interview with the official agency Télam, Kulfas was decisive: “Cannabis can have a great export development.”
The Minister of Productive Development defended the bill to regulate the chain of production, industrialization, and commercialization of the cannabis plant. Also, cannabis seeds and derived products for industrial and medicinal use, during a plenary session of commissions in the Senate.
Kulfas anticipated that the law will allow Argentina “to enter an international market with a quality and traceable product.” The objective is clear: “to sell at the best possible price for the quality it presents.”
Argentina is determined to export cannabis and does not want to waste any more time. That is why a plenary of Senate commissions began to debate the bill to regulate the chain of production, industrialization, and commercialization of the cannabis plant, its seeds, and derived products for industrial and medicinal use.
Read more about cannabis exports in Argentina and find the latest cannabis news in the world with the Hemp.im mobile app,
The intention is to sign an opinion next Monday and take it to the plenary sessions in mid-July
On the first day, the legislators that make up the Agriculture, Livestock, and Fishing, Budget and Finance, and Internal Security and Drug Trafficking Committees heard the Minister of Productive Development, Matías Kulfas.
The Government’s strong man on the subject said that the export of cannabis could mean an annual income of 50 million dollars and the creation of 10,000 jobs.
How Argentina seeks to enter the cannabis export market
The project establishes a regulatory framework for the production chain, including scientific research with a view to satisfy the local market and generate cannabis exports.
The regulatory framework sent by the Executive Power to Congress not only wants to export cannabis but also seeks to “disrupt the informal market of oils and other irregular herbal preparations that currently exists”.
It also promises that it will “put an end to the proliferation of products that lack any kind of control regarding their composition and quality.”
“We would like this law to be able to position us as a country brand. Because this industry can have great export development and a lot of international presence,” said Kulfas, the main promoter to achieve the export of cannabis in Argentina.
The first objective of the project consists of “establishing a legal framework that authorizes the stages of sowing, cultivation, harvesting, production, storage, transport and commercialization”.
Also “import, export and possession of cannabis seeds, the cannabis plant, and its derivatives, for medicinal, therapeutic, palliative or scientific research purposes”.
They hope to achieve this through a strong regulatory scheme
The second objective, as detailed in the initiative, “consists of legalizing the different products and commercialization links of hemp or industrial hemp and its by-products”.
In addition, it is clarified that “although hemp is not a narcotic drug under the terms of criminal law because it does not generate psychoactive effects, it is necessary to regulate and control the activity to prevent illegal crops of psychoactive cannabis from being hidden in hemp fields”.
Cannabis export in Argentina, a source of employment
The medical cannabis and industrial hemp market is growing exponentially and will be a source of quality employment, as promised by the Government of Argentina. When analyzing applications for licenses to produce medical or industrial marijuana, requirements and background information will be established and requested from the applicant before exporting cannabis. That is to “maximize controls aimed at preventing illegal activities, including money laundering.”
In granting licenses, ARICCAME will consider “the purpose of contributing to the development of regional economies and promoting the activity of cooperatives and small and medium agricultural producers.”
The bill also contemplates sanctions for non-compliance with the regulations: from a warning to disqualification to operate within the terms established, including fines, suspension, and the expiration of the authorization.
He also anticipated that the law will allow Argentina “to enter an international market with a quality and traceable product” so that “we can sell at the best possible price for the quality it presents.”
“This is an industry that can be developed in a decentralized way because there is room for everyone: for SMEs, small producers, and large companies,” added Kulfas.
The official listed that the law, once it is sanctioned, will allow the “creation of quality jobs, the generation of foreign currency from exports and development opportunities for the whole country.”
“Conservative estimates indicate that between now and 2025, 10,000 new jobs will be created,” he said.
In addition, he predicted that, per year, industrialization will generate “$500 million in sales to the domestic market and $50 million in cannabis exports.”
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in LA MARIHUANA, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The TopRanked.io Weekly Digest: What’s Hot in Affiliate Marketing [uMobix Affiliate Program Review]
This week, we're covering everything from hustle culture to spying on kids, making this affiliate digest look like it has...
Stanford University Returns Millions from FTX
Between November 2021 and May 2022, Bankman directed donations of more than €5.5 million from FTX Group to Stanford University....
Biova Project Launched an Equity Crowdfunding Campaign on Mamacrowd
Biova Project makes deals with players in large-scale distribution and production to recover, store, and transform unsold food, or food...
Novo Nordisk Plans to Open a Tech Headquarters in Spain
Novo Nordisk increased its profit by 42.5% in the first half of 2023, reaching 39,242 million Danish crowns (€5.26 million)....
Immorente Invest Maintains its Financial Stability
Although the occupancy rate has fallen from 92% to 90.2% compared with the end of 2022, the company expects this...
Biotech1 week ago
Asabys Partners Leads a €14 Million Round in Gradient Denervation
Markets2 weeks ago
Markets Are Looking Iffy, but That’s Seasonal
Biotech4 days ago
Vertex Obtains EMA Validation to Expand Indications for Kaftrio
Crowdfunding1 week ago
58 Crowdinvesting Platforms Authorized Under the New Regulation in Europe